Achondroplasia-First Report from India of a Rare FGFR3 Gene Variant

Lab Med. 2021 Sep 1;52(5):499-502. doi: 10.1093/labmed/lmaa116.

Abstract

The clinical manifestations of FGFR3 sequence variations can vary from mild unnoticed short stature to neonatal lethal dwarfism and can be causative of phenotypes including achondroplasia, hypochondroplasia, and thanatophoric dysplasia. Clinical data describe an 11 month old girl with restricted growth and preserved intellect. She had rhizomelic short stature with peculiar facies but no Acanthosis nigricans. In view of the absence of the hotspot mutation c.1138 G>A/G>C (p.Gly380Arg), complete gene sequencing was done that revealed a rare sequence variation, NM_000142.4:c.1043C>G (p.Ser348Cys) in FGFR3. This sequence variation has not been reported from India so far. This report emphasizes the benefit of sequencing the whole gene in individuals who are negative for hotspot mutation of achondroplasia with strong clinical suspicion.

Keywords: bioinformatics; bone; genetics; molecular diagnostics; pediatrics.

Publication types

  • Case Reports

MeSH terms

  • Acanthosis Nigricans
  • Achondroplasia* / diagnosis
  • Achondroplasia* / genetics
  • Female
  • Humans
  • Infant
  • Limb Deformities, Congenital
  • Lordosis
  • Mutation / genetics
  • Receptor, Fibroblast Growth Factor, Type 3 / genetics*
  • Thanatophoric Dysplasia

Substances

  • FGFR3 protein, human
  • Receptor, Fibroblast Growth Factor, Type 3